A tool to help brain surgeons test and more precisely remove cancerous tissue was successfully used during surgery, according to a Purdue University and Brigham and Women's Hospital study.
Jul 3, 2014
0
0
Astrocytomas and oligodendrogliomas are subtypes of a brain cancer called 'glioma'. These incurable brain tumors arise from glial cells, a type of support cell found in the central nervous system. "Low-grade gliomas", which ...
Jun 25, 2014
0
1
A blue-ribbon team of national experts on brain cancer says that professional pessimism and out-of-date "myths," rather than current science, are guiding—and compromising—the care of patients with cancers that spread ...
Jun 24, 2014
0
0
Unlike most other forms of cancer, medulloblastomas exhibits very few mutations in growth-promoting genes. In collaboration with an international team of colleagues, scientists from the German Cancer Research Center have ...
Jun 23, 2014
0
0
(Medical Xpress)—The hormone progesterone could become part of therapy against the most aggressive form of brain cancer. High concentrations of progesterone kill glioblastoma cells and inhibit tumor growth when the tumors ...
Jun 19, 2014
0
0
The Virginia G. Piper Cancer Center at Scottsdale Healthcare and the Translational Genomics Research Institute (TGen) are studying the safety and effectiveness of a new drug, AG-120, for treatment of patients with solid tumors, ...
Jun 17, 2014
0
1
Scientists from the Broad Institute and Massachusetts General Hospital (MGH) have conducted a first-of-its-kind study that characterizes the cellular diversity within glioblastoma tumors from patients. The study, which looked ...
Jun 12, 2014
0
0
Scientists at the University of Wisconsin Carbone Cancer Center (UWCCC) report that a new class of tumor-targeting agents can seek out and find dozens of solid tumors, even illuminating brain cancer stem cells that resist ...
Jun 11, 2014
0
1
Unfortunately, the most common form of brain cancer, glioblastoma, is also one of the deadliest and most difficult to treat. The statistics are stark: it kills about 95 percent of its victims within five years of diagnosis.
Jun 5, 2014
0
0
Researchers at Mayo Clinic have demonstrated in a mouse model that their recently developed synthetic peptide carrier is a potential delivery vehicle for brain cancer chemotherapy drugs and other neurological medications. ...
Jun 4, 2014
0
0
